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Abstract
Background: There are no studies done to evaluate the distribution of mammographic breast density and factors
associated with it among Pakistani women.
Methods: Participants included 477 women, who had received either diagnostic or screening mammography at two
hospitals in Karachi Pakistan. Mammographic breast density was assessed using the Breast Imaging Reporting and
Data System. In person interviews were conducted using a detailed questionnaire, to assess risk factors of interest, and
venous blood was collected to measure serum vitamin D level at the end of the interview. To determine the association of potential factors with mammographic breast density, multivariable polytomous logistic regression was used.
Results: High-density mammographic breast density (heterogeneously and dense categories) was high and found in
62.4% of women. There was a significant association of both heterogeneously dense and dense breasts with women
of a younger age group < 45 years (OR 2.68, 95% CI 1.60–4.49) and (OR 4.83, 95% CI 2.54–9.16) respectively. Women
with heterogeneously dense and dense breasts versus fatty and fibroglandular breasts had a higher history of benign
breast disease (OR 1.90, 95% CI 1.14–3.17) and (OR 3.61, 95% CI 1.90–6.86) respectively. There was an inverse relationship between breast density and body mass index. Women with dense breasts and heterogeneously dense breasts
had lower body mass index (OR 0.94 95% CI 0.90–0.99) and (OR 0.81, 95% CI 0.76–0.87) respectively. There was no
association of mammographic breast density with serum vitamin D levels, diet, and breast cancer.
Conclusions: The findings of a positive association of higher mammographic density with younger age and benign
breast disease and a negative association between body mass index and breast density are important findings that
need to be considered in developing screening guidelines for the Pakistani population.
Keywords: Breast cancer, Mammographic breast density, Age, Benign breast disease, Body mass index
Background
Mammography (MMG) is the baseline investigation
used for screening and diagnosis of breast cancer, which
remains responsible for more than 500,000 deaths each
year worldwide [1]. Mammographic breast density
(MBD) refers to the relative amount of dense tissue in
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an entire breast. Dense tissue comprises of connective
and epithelial tissue including glandular parenchyma
and hinders X-Ray transmission and therefore, appears
dense/white on mammography. Fatty parenchyma allows
unhindered X-ray transmission and hence appears
darker/lucent on a mammogram. Dense breast tissue
results in masking for breast cancer and hence the mammographic sensitivity is reduced with increasing MBD
[2]. Increased MBD is reported to decrease the sensitivity of screening mammography by 48%, in comparison to
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the 78% mammographic sensitivity of the entire sample
of the study [3]. Moreover, MBD has been recognized as
an independent risk factor for breast cancer incidence
and recurrence [4]. More than 50% of women in less than
50 years of age in the USA are reported to have dense
breasts [5]. Therefore, there has been a lot of interest in
the evaluation of factors associated with MBD including
the role of environment and genetics and the causal relationship between breast cancer and MBD.
Several factors can affect MBD like age, heredity, parity, ethnicity, diet, hormonal replacement therapy (HRT),
and the molecular subtypes of breast cancer [6, 7]. An
increasing parity status has been inversely associated
with MBD and the percent breast density [8]. MG del
Carmen et al. compared breast density among different
races and reported MBD to be lowest in white and African American women and highest in Asian women [9].
Race and ethnicity have been explored and identified as
important determinants of MBD in another study too
[10]. Though race and ethnicity are relevant to breast
density, other factors such as diet, and environmental
exposures are also important determinants of mammographic density and hence the risk of breast cancer
is different in different ethnic groups [11]. There is an
inverse association of body weight with the percentage
of MBD in both pre and post-menopausal women due
to more fat in the breast. It was recently confirmed in
another retrospective study showing association of surgical weight loss with a decrease in breast density [12].
Few other studies reported a higher intake of fats, protein, alcohol, and hormonal replacement therapy (HRT)
with higher MBD [13, 14]. Tamoxifen, however, reduced
MBD in short term, and in a randomized control trial,
a 10% reduction in MBD with a 63% breast cancer risk
reduction was reported [15]. MBD is also reported to be
heritable and has shown a correlation coefficient of 0.74
in monozygotic twins in comparison to 0.38 in dizygotic
twins [16]. However, the exact influence of the environment and individual’s behavior on this heritable effect is
still not clearly known.
There is no organized (service) screening program
in Pakistan and most of the mammography done is
opportunistic (individual) screening [17]. Due to limited screening mammography units and screening practices, there is a paucity of epidemiological data on MBD
prevalence and factors associated with MBD in Pakistan. Therefore, the joint effects of sociodemographic
and other factors associated with MBD among Pakistani
women remain unclear. The main objective of this study
was to evaluate the factors associated with MBD including serum level of vitamin D, intake of different food
categories, physical activity, body mass index BMI, and
other risk factors of breast cancer. Another objective
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was to assess the association of MBD with breast cancer
among Pakistani women.

Materials and methods
The source population of this study is from a multicenter
hospital-based case-control study which was conducted
at two large tertiary care hospitals of Karachi, the details
of the study and the questionnaire used are described in
the previously published article [18]. Briefly, 477 women
with complete records of MBD were extracted from the
main study. We included women of ages 30–74 years subjects from the main study who underwent a screening
mammogram between 2015 and 2019. There were 178
breast cancer cases and 299 controls who went diagnostic and screening (annual and biennial) mammography.
Women were included even if they had multiple mammograms. Women were excluded if they were unable to
complete the interview due to any sickness or been living
outside Pakistan for more than a year. We also excluded
women if mammographic breast density information was
unavailable. All mammograms were taken before breast
cancer diagnosis among cases. All subjects completed
an interview-based questionnaire that included information on age, education, socioeconomic status, parity, age
of mother at first birth, breastfeeding, age at menarche
and menopause, age of mother at first birth, history of
any comorbid or benign breast disease, family history of
breast cancer. Menopausal status was either premenopausal or postmenopausal. Participants also reported the
average number of hours per week, engaged in physical
activity of different intensities for at least 10 min, like
vigorous exercise or moderate exercise of household
activities like mopping, etc., and walking. BMI (kg/m2)
and tumor characteristics were recorded from medical
files and reports. Women with missing information of
BI-RADS (Breast Imaging-Reporting and Data System)
density were excluded. All consenting participants were
interviewed, after informed consent, in a separate room
to ensure privacy using a structured questionnaire.
Mammography measurement details

Two view mammography was performed for all
patients comprising of medio-lateral oblique (MLO)
and cranio-caudal (CC) views on a computed radiography (CR) system. In the CR system, the X- Rays passing through the breast, grid, and cassette cover are
absorbed by the plate reader system that comprises
photostimulable storage phosphor (PSP). An electronic latent image is produced on the PSP due to the
local absorption of X-ray energy that varies with the
anatomical variation of breast parenchyma. The cassette is subsequently placed in the reader that captures
the information and converts it to a digital signal that
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is finally displayed at the workstation [19]. The soft
copies of the mammographic images were downloaded
and reviewed at picture archiving and communication system (PACS) by breast imagers, and qualitative assessment of mammographic density was done
by dedicated radiologists with years of experience in
interpreting mammography and breast density.
Assessment of mammographic breast density (MBD)

Using the American College of Radiology Breast Imaging Reporting and Data System (ACR BI-RADS 5th
edition), the mammographic breast density on mammograms was categorized as; Category 1, Predominantly fatty (less than 25% glandular); category 2 for
scattered fibroglandular (25–50% glandular); category
3 for heterogeneously dense (51–75% glandular) and
category 4 for dense breast parenchyma (more than
75% glandular) [20]. Categories 3 and 4 both are high
MBD (Figs. 1 and 2 showing fatty and dense breast
parenchyma). Analyses were restricted to patients
with an available BI-RADS measurement. The density
measurements of the breast contralateral to the tumor
were used to avoid a distortion of measurements due
to the tumor itself.

Fig. 1 MLO and CC views of left breast showing fatty breast parenchyma
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Dietary intake assessment with a Food Frequency
Questionnaire (FFQ)

Dietary intake assessment was done by using the validated food frequency questionnaire FFQ [21]. Intake frequency was categorized into 7 groups and category for
each food item was converted to daily intake. Each participant was also asked about their average portion size/
common serving size of the food. The intake frequencies were multiplied by standard portion size to calculate
servings per day of all food items. All the food items were
grouped into six components including fruits, vegetables, dairy, grains, white meat, red meat, and plant proteins and total servings/day was calculated for each food
category.
Measurement of serum 25 (OH)D level

After the interview, blood samples were collected from
the study participants and serum 25 (OH)D level was
measured using ELISA.
Tumor characteristics

Histopathology and estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor
receptor (HER2/neu) status of breast cancer cases were
retrieved from medical records [22].
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Fig. 2 MLO and CC views of left breast showing dense breast parenchyma

The ethical approval was obtained by the Human
Research Ethics Committee of the University of Adelaide and the Ethical Review Committees of two hospitals in Karachi Pakistan: Aga Khan University Hospital
AKUH and Karachi Institute of Radiation and Nuclear
Medicine Hospital KIRAN. Patients who were literate read and signed the informed consent form and
informed consent was obtained verbally from those
who could not read or write.

Results
The mean age of the study participants was 46.2 years
(SD 11.7). Hundred and eighty (37.3%) women had
breast biopsy-proven breast cancer and 297 (62.7%)
of the women had normal or benign breast disease.
Figure 3 shows that high density MBD (heterogeneously and dense categories) accounted for 62.4% of all
participants.

Statistical analysis

Multinomial logistic regression models were applied to
compute odds ratios (ORs) and 95% confidence intervals (CIs) for the MBD categories. The fatty and scattered fibroglandular tissue categories were merged and
used as a reference. Multivariate models were adjusted
for variables found to be significantly associated with
breast density and known risk factors for breast cancer
such as age, BMI, age at menarche and menopause in
the postmenopausal group, parity, and family history
of breast cancer among first-degree relatives, BMI, and
the food categories. SPSS 22.0 software (IBM Statistics,
Armonk, New York, USA) was used for the analysis.

Percent
16.3

12.4
25.3

46.1

fay

scaered fibroglandular

heterogenously dense

dense

Fig. 3 Pie chart depicting the distribution of MBD among Pakistani
women
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Table 1 Characteristics of study participants by mammographic breast density among women in Karachi, Pakistan (n = 477)
Variables

Category

Fatty/
fibroglandular
(n = 178)

Heterogeneously
dense (n = 198)

Dense (n = 101)

n (%)

n (%)

n (%)

< 35

7 (3.9)

12 (6.1)

13 (12.9)

35–45

30 (16.9)

69 (34.8)

46 (45.5)

46–54

57 (32.0)

51 (25.8)

29 (28.7)

55 and above

84 (47.2)

66 (33.3)

13 (12.9)

< Grade8

33 (18.6)

31 (15.7)

13 (12.9)

Grades 8–12

65 (36.7)

54 (27.4)

24 (23.8)

> Grade12

79 (44.6)

112 (56.9)

64 (63.4)

Upper

43 (25.6)

48 (25.3)

20 (20.0)

Middle

114 (67.9)

129 (67.9)

73 (73.0)

Lower

11 (6.5)

13 (6.8)

7 (7.0)

Nullipara

21 (12.5)

18 (9.5)

21 (21.0)

1–3

78 (46.4)

112 (58.9)

55 (55.0)

>3

69 (41.1)

60 (31.6)

24 (24.0)

< 20 years

39 (25.8)

29 (16.2)

11 (13.9)

20–29 years

98 (64.9)

126 (70.4)

54 (68.4)

> 30 years

14 (9.3)

24 (13.4)

14 (17.7)

< 12 months

26 (19.3)

35 (21.2)

15 (19.7)

> 12 months

109 (80.7)

130 (78.8)

61 (80.3)

< 12 years

26 (16.3)

22 (12.2)

12 (12.6)

12–13 years

95 (59.4)

105 (58.0)

51 (53.7)

> 14 years

39 (24.4)

54 (29.8)

32 (33.7)

Yes

102 (57.3)

95 (48.0)

39 (38.6)

No

76 (42.7)

103 (52.0)

62 (61.4)

Yes

33 (19.9)

61 (32.6)

46 (46.5)

No

133 (80.1)

126 (67.4)

53 (53.5)

Yes

48 (28.6)

77 (40.7)

32 (32.0)

No

120 (71.4)

112 (59.3)

68 (68.0)

Menopause

125 (74.4)

102 (54.3)

40 (40.4)

Premenopause

43 (25.6)

86 (45.7)

59 (59.6)

< 20

78 (57.4)

82 (54.7)

47 (54.7)

20–30

21 (15.4)

30 (20.0)

19 (22.1)

> 30

37 (27.2)

38 (25.3)

20 (23.3)

Menopausal women

30.4 (4.8)

28.4 (4.9)

25.4 (4.2)

< 0.001

Premenopausal women

27.9 (5.0)

28.2 (4.7)

25.0 (3.8))

< 0.001

Age groups (years)

< 0.001

Education

0.023

Socioeconomic Status SES

0.866

Parity

0.004

Age of mother at first live birth (AFB)

0.060

Breastfeeding duration

0.910

Age at menarche (years)

0.487

History of any comorbid

0.01

History of benign breast disease

0.001

Family history of breast cancer

< 0–001

Menopausal status

< 0.001

Serum vitamin D level (ng/ml)

Mean BMI (SD)

p value*

0.761

BI-RADS: Breast Imaging Reporting and Data System (fatty and scattered glandular dense = categories A and B, heterogeneously dense = C, dense = D); chi-square
test*
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Table 2 Tumor characteristics of breast cancer cases according to mammographic breast density among women in Karachi Pakistan
(n = 178)
Hormonal receptor (IHC)

Fatty/fibroglandular (n = 178)

Heterogeneously dense (n = 198) Dense (n = 101)
n (%)

n (%)

Positive

41 (65.1)

59 (73.8)

22 (75.9)

Negative

22 (34.9)

21 (26.3)

7 (24.1)

Positive

37 (58.7)

59 (73.8)

19 (65.5)

Negative

26 (41.3)

21 (26.3)

10 (34.5)

Positive

10 (17.5)

16 (23.2)

7 (25.0)

Negative

47 (82.5)

53 (76.8)

21 (75.0)

TNBC

17 (27)

11 (14.1)

4 (13.8)

Non-TNBC

46 (73)

67 (85.9)

25 (86.2)

n (%)

p value*

0.428

ER

0.164

PR

0.65

Her2

0.113

TNBC

BI-RADS: Breast Imaging Reporting and Data System (fatty and scattered glandular dense = categories A and B, heterogeneously dense = C, dense = D); TN: triplenegative; ER: estrogen receptor; PR: progesterone receptor; HER2: human epidermal growth factor 2; chi-square test*

Characteristics of study participants

Table 1 shows that there were significant differences in
age, education, parity, breastfeeding, body weight, BMI,
parity, history of breastfeeding, history of comorbid,
menopausal status, among women of different breast
densities. In both heterogeneously dense and dense
groups, there was a higher percentage of women who
were of younger age categories, nullipara, lower parity, higher education, and had a family history of breast
cancer.
Tumor characteristics

There was no significant difference observed in the
tumor characteristics among different MBD categories
(Table 2).
There was a positive association of MBD with young
age, nulliparity and low parity, family history of breast
cancer and history of benign breast disease BBD. Significant protective association of MBD was observed for
women of younger age, menopausal status, younger age
at first birth (<20 years AFB) and BMI (Table 3).
Diet and breast density

There was no association reported between different
MBD and food categories of grains, fruits, vegetables,
plant proteins, dairy products, white and red meat as
shown in Table 4.
Multivariable analysis using multinomial logistic
regression (Table 5) shows that women with dense and
heterogeneously dense breasts versus fatty and fibroglandular breasts were of a younger age group and had higher
benign breast disease BBD. An inverse relationship of

BMI with MBD was also observed. There was no association of serum vitamin D levels or breast cancer with
breast density.

Discussion
The study findings of significant association of younger
age and BBD with higher MBD and protective association of higher BMI are consistent with other studies.
Younger age as an important determinant of a high MBD
is similar to other studies done in different populations
[23–27]. In another study, there was a decline in density
reported with age in women with and without breast
cancer [28]. It supports the hypothesis that breast density
declines with age as younger women have a higher proportion of dense breast tissue compared to older women
[6]. In a study done on data from the San Francisco Mammography Registry, breast density decreased with age on
an annual basis over the perimenopausal stage [29]. Our
findings provide important data on the association of
benign breast disease with higher mammographic breast
density and are similar to other studies [30–32].
In our study, the inverse relationship between MBD
and higher BMI remained the same in both menopausal and premenopausal women. The inverse relationship
between BMI and MBD has been reported in previous
studies among both menopausal and premenopausal
women [23, 33, 34]. In the Minnesota Breast Cancer Family Study, higher BMI was associated with lower breast
density among postmenopausal women only [35]. BMI
was also inversely related to MBD in Chinese women
[36]. An inverse relationship of greater body weight with
percentage mammographic density was also reported in
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Table 3 Association of factors with mammographic breast density using odds ratios (OR) and 95% confidence intervals (CI), among
women in Karachi, Pakistan
Variable

Age (years)

Socioeconomic status

Parity

AFB* (years)

Breastfeeding duration
Age at menarche

Menopause
Age at menopause
History of benign
Breast cancer

Category

Vitamin D (ng/ml)

Dense

OR

95%CI

OR

95%CI

< 35

2.18

0.81, 5.85

12.00

4.04, 35.65

35–45

2.93

1.65, 4.92

9.91

4.71, 20.84

46–54

1.14

0.69, 1.87

3.29

1.58, 6.86

55 and above

Ref

Upper

0.94

0.38, 2.32

0.73

0.24, 2.17

Middle

0.95

0.41, 2.22

1.00

0.37, 2.71

Lower

Ref

Nullipara

0.95

0.47, 1.93

2.79

1.32, 5.91

<3

1.63

1.05, 2.53

1.94

1.10, 3.41

>3

Ref

Ref

Ref

Ref

< 20

0.42

0.18, 0.97

0.28

0.10, 0.76

20–29

0.79

0.38, 1.65

0.54

0.23, 1.22

> 30

Ref

< 12 months

1.13

> 12 months

Ref

Ref
0.65, 1.95

1.09

0.55, 2.16

Ref

< 12yrs

0.61

0.30, 1.23

0.56

0.25, 1.29

12-13yrs

0.8

0.49, 1.31

0.65

0.37, 1.17

> 14yrs

Ref

Menopause

0.38

Premenopause

Ref

< 45

0.92

> 45

Ref

Yes

1.72

No

Ref

Yes

1.71

No

Ref

BMI (kg/m2)*
Physical activity* (h/week)

Heterogeneously dense

Ref
0.24, 0.59

0.21

0.13, 0.36

Ref
0.48, 1.78

2.02

0.82, 5.01

Ref
1.08, 2.73

2.99

1.76, 5.09

Ref
0.77, 1.77

0.66

0.39, 1.13

Ref

0.94

0.90, 0.98

0.80

0.75, 0.86

Walking

0.99

0.89, 1.09

0.95

0.83, 1.09

Moderate exercise

1.02

0.98, 1.05

1.00

0.96, 1.05

Vigorous exercise

Ref

Ref

< 20

1.02

0.59, 1.77

1.12

0.58, 2.14

20–30

1.39

0.68, 2.85

1.67

0.73, 3.82

> 30

1 (Ref )

1 (Ref )

Fatty and scattered glandular combined as the reference group. BI-RADS: Breast Imaging Reporting and Data System (fatty and scattered glandular dense = categories
A and B, heterogeneously dense = C, dense = D); BMI: body mass index OR: odds ratio; 95% CI: 95% confidence interval AFB Age at first birth* mean (SD)*

premenopausal women, with mammogram showing a
larger area of fatty tissue caused by an increased quantity
of fat in the breast [37].
Similar to our study findings, a study among Japanese women reported that younger age and BMI were
inversely related to high MBD [38]. In another breast
cancer family study of 426 families, younger age and
lower BMI were associated with increased MBD in both
premenopausal and postmenopausal women. Hormone
replacement therapy among postmenopausal women was
also associated with MBD but this association of MBD

with hormone replacement therapy was not seen in the
current study as HRT use is very small among Pakistani
women. In a study in Norway, volumetric mammographic density (VMD) was inversely associated with age
and BMI which is consistent to our study findings [31,
39]. A negative association of high MBD with age, low
parity and BMI, was similarly reported by other studies
[40, 41].
However, this study observed no association between
MBD and breast cancer, and this lack of association has
also been reported in a study done in the USA [42] and
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Table 4 Association between average servings per day of different food categories and mammographic breast density among
women in Karachi, Pakistan
Food categories

Heterogeneously dense

Dense

OR

95% CI

OR

95% CI

Grains per day

1.00

0.87

1.16

1.08

0.92

1.27

Vegetables per day

0.98

0.91

1.06

1.04

0.95

1.13

Fruits per day

0.97

0.87

1.09

0.99

0.87

1.13

Dairy products per day

0.84

0.72

0.97

0.93

0.78

1.1

Red meat per day

1.02

0.78

1.33

1.14

0.85

1.53

White meat per day

1.15

0.81

1.62

1.17

0.79

1.75

Plant proteins per day

0.91

0.75

1.11

0.85

0.67

1.07

Fatty and scattered glandular combined as the reference group
OR, odds ratio; 95% CI, 95% confidence interval

Table 5 Adjusted Odds Ratios (95% CI) for factors associated
with mammographic breast density among women in Karachi,
Pakistan
Category

Heterogeneously dense
MBD

Dense MBD

Variables

AOR

95% CI

AOR

95% CI

< 45

2.68

1.60, 4.49

4.83

2.54, 9.16

> 45

Ref

Age (years)
Ref

History of benign
breast disease
Yes

1.90

No

Ref

BMI*

0.94

1.14, 3.17

3.61

1.90, 6.86

Ref
0.90, 0.99

0.81

0.76, 0.87

Ref is fatty/fibroglandular category. BI-RADS: Breast Imaging Reporting
and Data System (fatty and scattered glandular dense = categories A and B,
heterogeneously dense = C, dense = D)
AOR, adjusted odds ratio; 95% CI, 95% confidence interval; *mean (SD)

AORs adjusted for socioeconomic status, vitamin D, parity, diet, menopausal
status/age at menopause, age at first birth, family history of breast cancer,
exercise, and case–control status of women

one in China [42]. A nested case-control study in Ontario,
Canada also reported no association of MBD with breast
cancer among women with BRCA mutation[43]. Another
study at the Massachusetts General Hospital showed that
while Asians had the highest breast density, the incidence
of breast cancer among them was lesser than that among
white women [13]. An observational study of the Mayo
Clinic Benign Breast Disease (BBD) cohort failed to find
any evidence of an association between MBD and breast
cancer risk in women diagnosed with BBD of atypical
hyperplasia (AH) type [44]. Similarly, another study done
at Johns Hopkins showed that breast cancer was not
associated with MRI breast density [45]. The study findings did not show any association of MBD with vitamin

D levels, similar to the Nurses’ Health Study [46]. There
was also no association observed between MBD and diet.
The high percentage of high MBD (62.4%) in Pakistani
women is important information and will be helpful in
planning or advising for an organized screening mammography program in Pakistan in future. This is higher
than the reported percentage among women in the USA
[47] and lower than the reported percentage among
women in Jordon [48]. High density breast, on one
hand, increases the rates of false-negative diagnosis and
on the other hand, there is a requirement of additional
tests. The need for additional tests like ultrasound, and
MRI increases the sensitivity of screening programs [49]
but the cost then becomes too high for the majority of
the asymptomatic women to opt for regular screening as
there is no health insurance and high poverty in Pakistan.
Significant association of younger age with high MBD
in our study is an important finding because ACR guidelines are followed here in the absence of screening guidelines established for Pakistani women where mean age
at the time of breast cancer diagnosis reported is also
much younger compared to the women in America (46.1
years ± SD 10.1) [50]. Mammographic breast density was
also found to be positively associated with BBD and negatively associated with BMI. In univariate analysis, lower
parity, breastfeeding, and family history of breast cancer also showed a significant protective association with
dense breast. However, in a multivariate analysis performed to adjust for confounding factors, only younger
age, BBD, and BMI remained as significant factors associated with high breast density.
Limitations

Study limitations include small sample size and limited
generalizability of the study population due to lack of any
organized screening mammography program in Pakistan.
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Moreover, there was no availability of digital radiography (DR) which was installed in 2019, after the completion of the data collection period of the study. We could
not calculate percentage density and absolute dense area
due to the lack of availability of the software. There is
still a lack of standardization in MBD assessment with
high density definitions varying widely from 25 to 75%
of dense tissues on mammograms in different studies.
Though we tried our best to evaluate MBD with standard
mammographic procedures, breast density classification
as well as a standardized definition of MBD. Still, some
misclassification of MBD could have affected our results
since we used visual classification using BI RADS by two
experienced radiologists. However, a study reported very
good agreement between automatic assessment software
of breast density based on artificial intelligence (AI) and
visual assessment by a senior and a junior radiologist
[51]. The strengths of the study are a good quality of data
collection by medical doctors, and comprehensive assessment of all factors associated with MBD.
Conclusion and recommendations

To our knowledge, this study is the first to report unique
distribution of MBD and identify factors associated with
MBD in Pakistani women. The findings of positive association of higher mammographic density younger age
and BBD and negative association between BMI and
breast density are consistent with predictors of mammographic density observed in other populations; however,
certain risk factors were not significantly associated with
BMD. These are important findings which may be helpful
to develop screening guidelines for Pakistani population.
Given the current role of breast density in determining
breast cancer screening protocols, public health policy,
and future research directions, it is important to validate our findings in a larger scale investigation with the
advanced technology of the DR system and assess if it is
better than screen-film mammography in women with
dense breasts.
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